n/a
Abstract Title:

Pharmacological Therapy Determines the Gut Microbiota Modulation by a Pomegranate Extract Nutraceutical in Metabolic Syndrome: A Randomized Clinical Trial.

Abstract Source:

Mol Nutr Food Res. 2021 Dec 22:e2001048. Epub 2021 Dec 22. PMID: 33458928

Abstract Author(s):

Adrián Cortés-Martín, Carlos Eduardo Iglesias-Aguirre, Amparo Meoro, María Victoria Selma, Juan Carlos Espín

Article Affiliation:

Adrián Cortés-Martín

Abstract:

SCOPE: Poly-pharmacological therapy shapes the gut microbiota (GM) in metabolic syndrome (MetS) patients. The effects of polyphenol-rich sources in poly-medicated MetS patients are unknown.

METHODS AND RESULTS: A randomized, placebo-controlled, double-blinded, and crossover trial in poly-medicated MetS patients (n = 50) explored whether the effects of a pomegranate extract nutraceutical (PE, 320 mg phenolics/day for one month) were affected by the drug therapy. We evaluated, considering the lipid-lowering (LL-), anti-hypertensive (HP-) and(or) anti-diabetic (AD-) treatments: GM (16S rRNA sequencing), short-chain fatty acids, 40 inflammatory-metabolic and endotoxemia-related biomarkers, associations between biomarkers and GM with 53 cardiometabolic dysfunctions-related single-nucleotide polymorphisms (SNPs), and the influence of urolithin metabotypes (UMs). Representative SNPs-GM associations after PE included Lactococcus and ClostridiumXIVa with rs5443-GNB3 and ClostridiumXIVa withrs7903146-TCF7L2 and rs1137101-LEPR. PE decreased sICAM-1 in LL-patients and the lipopolysaccharide-binding protein in all the patients. PE did not affect the other patients' markers as a group or stratifying by UMs. After PE, Lactococcus increased in AD-, LL- and HP-patients, Bifidobacterium increased in LL- and AD-, while Clostridium XIVa decreased in non-LL- and non-HP-patients.

CONCLUSION: The prebiotic effect of PE depended on the medication, mainly on HP-treatments. Targeting GM could complement MetS therapy, but the patients' drug therapy should be considered individually. This article is protected by copyright. All rights reserved.

Study Type : Human Study

Print Options


Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.